Income statement, balance sheet and cash flow statement for the last 8 fiscal years, taken from the XBRL data Firy Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2018
FY2020
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
50.8
120
229
380
270
152
92.9
104
Cost of revenue
2.11
5.71
12.3
25.2
30.7
15.4
13.4
13.1
Gross profit
48.7
114
217
355
239
137
79.5
91.4
Research and development
7.55
11.2
23.2
46.2
52.3
28.1
16.7
20.6
Selling and marketing
51.7
111
254
467
277
123
76.4
71.1
General and administrative
15
16.4
42.5
136
163
96.7
78.9
71.1
Operating income
-25.5
-24.8
-103
-294
-421
-114
-46.5
-63.9
Interest expense
2.19
2.5
1.33
1.22
40.6
21.5
15.1
15.2
Interest income
14.1
18.6
15.4
9.43
Other non-operating income
-0.05
3.72
-21.4
0.05
0.13
0.54
-0.53
-0.57
Pre-tax income
-27.8
-23.6
-149
-207
-439
-101
-46.7
-70.3
Income tax
0
0
0.12
-19.1
-0.35
0.24
0.07
0.11
Net income
-27.8
-23.6
-149
-188
-439
-101
-46.8
-70.4
EBITDA
-25.1
-24.1
-102
-282
-403
-112
-44.8
-62.5
EPS, basic
-2.50
-1.87
-10.20
-9.80
-21.41
-4.85
-2.62
-4.51
EPS, diluted
-2.50
-1.87
-10.20
-14.21
-21.41
-4.85
-2.62
-4.51
Shares, basic (weighted)
11.3
12.5
14.7
19.2
20.5
20.9
17.8
15.6
Shares, diluted (weighted)
11.3
12.5
14.7
19.4
20.5
20.9
17.8
15.6
Balance sheet
FY2018
FY2020
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
22.5
25.6
263
241
363
302
272
195
Short-term investments
0
319
127
0
0
0
Receivables
0
12.8
7.18
5.94
4.89
14.4
Other current assets
4.35
0.87
1.5
1.49
1.36
10.4
1.13
Total current assets
35.1
273
590
502
315
303
216
Property, plant and equipment
3.65
5.29
9.99
2.99
14.5
16.3
20.8
Lease right-of-use assets
14.5
0.47
0
0.31
1.08
Goodwill
0
85.9
0
Intangible assets
0
79.1
0
0
Long-term investments
0
183
56.7
1.13
0
0
Other non-current assets
0.12
3.91
3.48
0.85
2.69
0.76
1.35
Total assets
38.9
282
1,021
621
396
374
293
Accounts payable
2.94
22
19.8
1.7
1.71
9.8
9.71
Accrued liabilities
2.53
3.83
12.1
4.99
2.07
2.59
4.48
Short-term debt
0
0
128
Total current liabilities
10.5
55.3
99.8
49.5
49.9
65.9
181
Long-term debt
9.63
0
279
273
124
126
0
Lease liabilities
13.6
11.9
10.6
9.34
0.67
Other non-current liabilities
0.08
0.05
13.4
8.39
0.96
0.33
0.26
Total liabilities
20.2
234
412
343
185
201
182
Total debt
9.63
0
279
273
124
126
128
Paid-in capital
109
295
1,044
1,153
1,198
1,227
1,245
Retained earnings
-90.3
-246
-434
-873
-974
-1,021
-1,092
Treasury stock
0
-13
-32.3
-41.6
Other comprehensive income
0
-0.25
-1.56
-0.01
0
-0.37
Shareholders' equity
1.08
14.2
48.8
609
278
210
173
112
Total equity
1.08
14.2
48.8
609
278
210
173
112
Total liabilities and equity
38.9
282
1,021
621
396
374
293
Cash flow statement
FY2018
FY2020
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-27.8
-23.6
-149
-188
-439
-101
-46.8
-70.4
Depreciation and amortization
0.4
0.71
1.61
11.7
17.9
1.96
1.67
1.38
Stock-based compensation
6.68
1.24
23.8
60.3
108
43.7
30
19.6
Deferred income tax
0
0
0
-19.4
-0.7
0
0
0
Change in receivables
0
0
0.93
5.59
1.24
0.83
-9.51
Change in payables
1.85
-0.05
10.7
6.26
-17.2
0.02
7.02
0.41
Cash from operations
-16.9
-21.9
-56.2
-180
-180
-71.8
-7.07
-68.9
Capital expenditures
-0.87
-3.22
-3.25
-3.24
-1.89
-13.2
-0.67
-1.4
Acquisitions
0
0
-84
0
Purchases of investments
0
0
-504
-454
0
-0.01
0
Sales and maturities of investments
0
0
0
600
126
0
0
Cash from investing
-0.87
-3.22
-3.25
-644
311
168
-1.38
-6.14
Debt issued
19.9
9.56
0
281
0
Debt repaid
-5
-3.5
-10
0
0
Stock issued
0
0
0
402
0
Share buybacks
0
0
-1.34
0
0
-13
-19.3
-9.26
Cash from financing
33.3
31.2
297
803
-10.6
-150
-21.7
-11
Exchange rate effect
0
-0.37
Net change in cash
15.5
6.01
237
-21.4
121
-53.4
-30.1
-86.4
Free cash flow
-17.8
-25.2
-59.5
-183
-181
-85
-7.74
-70.3
Interest paid
0.2
0.27
0.82
0.18
30.3
18.3
13.4
13.3
Income taxes paid
0
0.4
0.18
0.15
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $12.42 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
87.8%
Gross profit / revenue.
Operating margin
-53.4%
Operating income / revenue.
EBITDA margin
-51.1%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-60.0%
Pre-tax income / revenue.
Net margin
-60.2%
Net income / revenue.
FCF margin
-52.3%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-52.6%
Cash from operations / revenue.
Return on equity (ROE)
-83.8%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-26.0%
Net income / average total assets.
Return on invested capital (ROIC)
-101.0%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue
19.5%
Research and development expense / revenue.
Stock-based pay / revenue
16.5%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
0.3%
Capital expenditures / revenue.
D&A / revenue
2.3%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
12.5%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-27.1%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
-14.5%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y
15.1%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
-27.4%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y
-15.9%
Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y
-35.4%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
-26.2%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y
18.0%
Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
-21.6%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-22.1%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
0.8%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
-12.6%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
-8.7%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
1.2%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
1.03x
Current assets / current liabilities.
Quick ratio
0.99x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.89x
(Cash + short-term investments) / current liabilities.
Debt / equity
1.52x
Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets
47.3%
Total debt / total assets.
Liabilities / assets
68.9%
Total liabilities / total assets.
Net debt
-$35.3M
Total debt - cash - short-term investments. Negative means more cash than debt.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$7.31
Revenue / diluted weighted shares.
FCF per share
-$3.82
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$3.85
Cash from operations / diluted weighted shares.
Book value per share
$5.25
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
1.65x
Market cap / revenue.
P/B
2.29x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
2.38x
Market cap / tangible book value, when positive.
EV/Sales
1.35x
Enterprise value / revenue.
FCF yield
-31.7%
Free cash flow / market cap.
Earnings yield
-36.5%
Net income / market cap (the inverse of P/E).
Shareholder yield
0.8%
(Dividends paid + share buybacks) / market cap.
What was Firy Inc.'s revenue in fiscal 2025?
Firy Inc. reported revenue of $104.5M for fiscal 2025, 12.5% higher than the year before.
Was Firy Inc. profitable in fiscal 2025?
No. It reported a net loss of $70.4M.
How much free cash flow did Firy Inc. generate in fiscal 2025?
Cash from operations of $68.9M minus capital expenditures of $1.4M left free cash flow of -$70.3M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.